GILD vs. MRK
Compare and contrast key facts about Gilead Sciences, Inc. (GILD) and Merck & Co., Inc. (MRK).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: GILD or MRK.
Key characteristics
GILD | MRK | |
---|---|---|
YTD Return | -18.53% | 18.39% |
1Y Return | -14.53% | 11.46% |
3Y Return (Ann) | 3.95% | 24.77% |
5Y Return (Ann) | 3.57% | 14.40% |
10Y Return (Ann) | 1.07% | 12.05% |
Sharpe Ratio | -0.72 | 0.68 |
Daily Std Dev | 21.56% | 17.34% |
Max Drawdown | -70.83% | -68.63% |
Current Drawdown | -27.61% | -2.80% |
Fundamentals
GILD | MRK | |
---|---|---|
Market Cap | $81.58B | $332.33B |
EPS | $4.50 | $0.91 |
PE Ratio | 14.54 | 144.18 |
PEG Ratio | 0.42 | 0.10 |
Revenue (TTM) | $27.45B | $61.40B |
Gross Profit (TTM) | $21.62B | $42.08B |
EBITDA (TTM) | $12.82B | $10.21B |
Correlation
The correlation between GILD and MRK is 0.27, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
GILD vs. MRK - Performance Comparison
In the year-to-date period, GILD achieves a -18.53% return, which is significantly lower than MRK's 18.39% return. Over the past 10 years, GILD has underperformed MRK with an annualized return of 1.07%, while MRK has yielded a comparatively higher 12.05% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
GILD vs. MRK - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Gilead Sciences, Inc. (GILD) and Merck & Co., Inc. (MRK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
GILD vs. MRK - Dividend Comparison
GILD's dividend yield for the trailing twelve months is around 4.62%, more than MRK's 2.34% yield.
TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Gilead Sciences, Inc. | 4.62% | 3.70% | 3.40% | 3.91% | 4.67% | 3.88% | 3.65% | 2.90% | 2.57% | 1.27% | 0.00% | 0.00% |
Merck & Co., Inc. | 2.34% | 2.72% | 2.52% | 3.41% | 3.03% | 2.48% | 2.60% | 3.36% | 3.14% | 3.42% | 3.11% | 3.45% |
Drawdowns
GILD vs. MRK - Drawdown Comparison
The maximum GILD drawdown since its inception was -70.83%, roughly equal to the maximum MRK drawdown of -68.63%. Use the drawdown chart below to compare losses from any high point for GILD and MRK. For additional features, visit the drawdowns tool.
Volatility
GILD vs. MRK - Volatility Comparison
Gilead Sciences, Inc. (GILD) has a higher volatility of 4.84% compared to Merck & Co., Inc. (MRK) at 4.17%. This indicates that GILD's price experiences larger fluctuations and is considered to be riskier than MRK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
GILD vs. MRK - Financials Comparison
This section allows you to compare key financial metrics between Gilead Sciences, Inc. and Merck & Co., Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities